{"title":"Risks to the 340B Drug Pricing Program Related to Manufacturer Restrictions on Drug Availability.","authors":"Ryan P Knox, Aaron S Kesselheim, Ameet Sarpatwari","doi":"10.1001/jama.2022.5959","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":49658,"journal":{"name":"Progress of Theoretical Physics","volume":"106 1","pages":"1647-1648"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress of Theoretical Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jama.2022.5959","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}